Sweden's Alleima Q2 revenue beats estimates on medical, industrial segments growth

Alleima AB

17/07/2026 10:40

Overview
Sweden-based advanced alloys maker's Q2 revenue rose 3% yr/yr, beating analyst expectations
Adjusted EBIT for Q2 rose to SEK 519 mln, margin improved to 10.6%
Company saw strong growth in medical and industrial heating segments, but market remains challenging

Outlook
Alleima expects annual cost savings of just over SEK 200 mln by year-end
Company anticipates increased production volumes from Tube Mill 2026 from year-end
Alleima sees ongoing market uncertainty likely to affect results in coming quarters

Result Drivers
SEGMENT GROWTH - Medical and Industrial Heating segments, along with seamless titanium tubes for aerospace, drove revenue growth
KANHAL DIVISION - Strong performance from Kanthal division contributed to improved adjusted EBIT margin
COST SAVINGS - Targeted measures to strengthen efficiency and competitiveness contributed SEK 45 mln to Q2 earnings

Company press release: ID:nWkr7DtJtm

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Beat
SEK 4.90 bln
SEK 4.67 bln (5 Analysts)
Q2 Adjusted EBIT
 
SEK 519 mln
 
Q2 Adjusted Free Cash Flow
 
SEK 330 mln
 

Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 2 "hold" and 2 "sell" or "strong sell"
The average consensus recommendation for the iron & steel peer group is "buy."
Wall Street's median 12-month price target for Alleima AB is SEK98.00, about 1.2% below its July 16 closing price of SEK99.15
The stock recently traded at 18 times the next 12-month earnings vs. a P/E of 15 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)